PDS Biotechnology

PDSB

1.1606.45% ( -0.080 )

Closed: Oct 22, 15:59:59 (EDT)

Current ValuationThe current P/E ratio is -2.06, within the reasonable range, cheaper than 60.92% of the time in the past 3 years, and the industry ranks 288/605, the industry Median -1.93.

-2.06xP/E

Stock price$1.24Earnings per share$-0.60

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

021426384

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GILDUSGilead Sciences	-58.77x	150.60%	$190.42B
MRNAUSModerna	-31.14x	15.78%	$98.14B
CSLLYUSCSL Limited	-25.46x	--	$65.67B
NTRAUSNatera	-309.79x	6.09%	$59.59B
RVMDUSRevolution Medicines	-23.55x	61.94%	$41.64B
ROIVUSRoivant Sciences	-99.84x	146.69%	$26.58B
BNTXUSBioNTech SE	-11.73x	19.62%	$22.93B
INSMUSInsmed	-23.46x	75.01%	$20.54B
BBIOUSBridgebio Pharma	-19.14x	28.60%	$13.24B
SMMTUSSummit Therapeutics	-14.75x	19.79%	$12.63B
MDGLUSMadrigal Pharma	-32.55x	51.30%	$10.58B
PCVXUSVaxcyte	-9.35x	47.91%	$9.95B
TWSTUSTwist Bioscience	-71.81x	28.71%	$9.82B
KYMRUSKymera Therapeutics	-31.26x	5.24%	$9.37B
IBRXUSImmunityBio	-9.23x	151.32%	$9.16B
CYTKUSCytokinetics	-9.78x	6.85%	$8.74B
ARWRUSArrowHead Pharma	-25.98x	35,923.70%	$8.31B
SYREUSSpyre Therapeutics	-54.56x	45.60%	$8.20B
ABVXUSAbivax SA	-17.53x	22.99%	$8.15B
IONSUSIonis Pharma	-13.02x	49.51%	$7.36B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.